Prevalence and clinical significance of antiphospholipid antibodies in patients with coronavirus disease 2019 admitted to intensive care units: a prospective observational study.

MLA

Najim, Mostafa, et al. “Prevalence and Clinical Significance of Antiphospholipid Antibodies in Patients with Coronavirus Disease 2019 Admitted to Intensive Care Units: A Prospective Observational Study.” Rheumatology International, vol. 41, no. 7, July 2021, pp. 1243–52. EBSCOhost, https://doi.org/10.1007/s00296-021-04875-7.

APA

Najim, M., Rahhal, A., Khir, F., Aljundi, A. H., Abu Yousef, S., Ibrahim, F., Amer, A., Mohamed, A. S., Saleh, S., Alfaridi, D., Mahfouz, A., Alyafei, S., Howady, F., Khatib, M., & Alemadi, S. A. (2021). Prevalence and clinical significance of antiphospholipid antibodies in patients with coronavirus disease 2019 admitted to intensive care units: a prospective observational study. Rheumatology International, 41(7), 1243–1252. https://doi.org/10.1007/s00296-021-04875-7

Chicago

Najim, Mostafa, Alaa Rahhal, Fadi Khir, Amer Hussien Aljundi, Safae Abu Yousef, Feryal Ibrahim, Aliaa Amer, et al. 2021. “Prevalence and Clinical Significance of Antiphospholipid Antibodies in Patients with Coronavirus Disease 2019 Admitted to Intensive Care Units: A Prospective Observational Study.” Rheumatology International 41 (7): 1243–52. doi:10.1007/s00296-021-04875-7.